Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.80 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | PLA2G4B | P0C869 | 8/20 | 0.62 |
| ▸ | RARB | P10826 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.55 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28627609 | 0.98 | PLA2G2A (0.77) | PLA2G2ATP53TSHRPLA2G4BRARB | |
| SCHEMBL10830829 | 0.96 | PLA2G2A (0.86) | PLA2G2ATP53TSHRPLA2G4BRARB | |
| SCHEMBL8733941 | 0.94 | PLA2G2A (0.90) | PLA2G2ATP53TSHRPLA2G4BRARB | |
| SCHEMBL1820396 | 0.93 | PLA2G2A (0.93) | PLA2G2ATP53TSHRPLA2G4BRARB | |
| SCHEMBL15955753 | 0.93 | PLA2G2A (0.93) | PLA2G2ATP53TSHRPLA2G4BRARB | |
| SCHEMBL1768821 | 0.93 | PLA2G2A (0.93) | PLA2G2ATP53TSHRPLA2G4BRARB | |
| SCHEMBL1768906 | 0.93 | PLA2G2A (0.93) | PLA2G2ATP53TSHRPLA2G4BRARB | |
| SCHEMBL28635177 | 0.91 | PLA2G2A (0.90) | PLA2G2ATP53TSHRPLA2G4BRARB | |
| SCHEMBL28630926 | 0.91 | PLA2G2A (0.90) | PLA2G2ATP53TSHRPLA2G4BRARB | |
| Hydrochloric Acid SCHEMBL4592930 | 0.91 | PLA2G2A (0.90) | PLA2G2ATP53TSHRPLA2G4BRARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7789943-B2 | Metal, ligand molecular sieves; temperature adjustable pores; controlling particle size | MIAMI UNIVERSITY (US) | 2010-09-07 | — | — | US | claimed |
| US-20080184881-A1 | MESH-ADJUSTABLE MOLECULAR SIEVE | MIAMI UNIVERSITY (US) | 2008-08-07 | — | — | US | claimed |
| US-20230150951-A1 | 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS | OM PHARMA SA (CH) | 2023-05-18 | — | — | US | disclosed |
| US-10440955-B2 | Methods comprising a biocidal polyamine | CURZA GLOBAL, LLC (US) | 2019-10-15 | — | — | US | disclosed |
| US-20180125070-A1 | COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE | THE UNIVERSITY OF UTAH | 2018-05-10 | — | — | US | disclosed |
| US-9839219-B2 | Compositions comprising a biocidal polyamine | CURZA GLOBAL, LLC (US) | 2017-12-12 | — | — | US | disclosed |
| US-20160330962-A1 | COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE | CURZA GLOBAL, LLC | 2016-11-17 | — | — | US | disclosed |
| US-9439433-B2 | Compositions and methods comprising a biocidal polyamine | CURZA GLOBAL, LLC (US) | 2016-09-13 | — | — | US | disclosed |
| EP-2999345-A1 | COMPOSITIONS AND METHODS COMPRISING A POLYAMINE | Curza Global LLC (US) | 2016-03-30 | — | — | EP | disclosed |
| US-20150038512-A1 | COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE | THE UNIVERSITY OF UTAH | 2015-02-05 | — | — | US | disclosed |
| WO-2014190096-A1 | COMPOSITIONS AND METHODS COMPRISING A POLYAMINE | CURZA GLOBAL, LLC (US) | 2014-11-27 | — | — | WO | disclosed |
| US-8362237-B2 | Optical-isomer separating agent for chromatography and process for producing the same | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2013-01-29 | — | — | US | disclosed |
| US-8337591-B2 | Mesh-adjustable molecular sieve | MIAMI UNIVERSITY (US) | 2012-12-25 | — | — | US | disclosed |
| US-20100292464-A1 | OPTICAL-ISOMER SEPARATING AGENT FOR CHROMATOGRAPHY AND PROCESS FOR PRODUCING THE SAME | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-11-18 | — | — | US | disclosed |
| US-7789943-B2 | Metal, ligand molecular sieves; temperature adjustable pores; controlling particle size | MIAMI UNIVERSITY (US) | 2010-09-07 | — | — | US | disclosed |
| US-20100170393-A1 | MESH-ADJUSTABLE MOLECULAR SIEVE | MIAMI UNIVERSITY (US) | 2010-07-08 | — | — | US | disclosed |
| US-20080184881-A1 | MESH-ADJUSTABLE MOLECULAR SIEVE | MIAMI UNIVERSITY (US) | 2008-08-07 | — | — | US | disclosed |
| US-7344704-B2 | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi | SCHERING AG (DE) | 2008-03-18 | — | — | US | disclosed |
| US-20070269384-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media for diagnosis of Alzheimer's disease | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-11-22 | — | — | US | disclosed |
| US-20070269384-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media for diagnosis of Alzheimer's disease | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150951-A1 | 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS | HRH4, NCOA4, HRH3 | PLA2G2A 2298/4885TP53 1847/4885TSHR 1884/4885 |
| US-20080184881-A1 | MESH-ADJUSTABLE MOLECULAR SIEVE | TRPA1, TRPM4, TRPV4 | PLA2G2A 2737/4885TP53 593/4885TSHR 2696/4885 |
| US-20160330962-A1 | COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE | SRM, SMS, SMOX | PLA2G2A 1304/4885TP53 2933/4885TSHR 4339/4885 |
| US-20070269384-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media for diagnosis of Alzheimer's disease | APP, APBA1, PSEN1 | PLA2G2A 643/4885TP53 300/4885TSHR 1511/4885 |
| US-10440955-B2 | Methods comprising a biocidal polyamine | SRM, SMOX, SMS | PLA2G2A 1300/4885TP53 3345/4885TSHR 4247/4885 |
| US-20180125070-A1 | COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE | SRM, SMOX, SMS | PLA2G2A 1121/4885TP53 2932/4885TSHR 4388/4885 |
| US-20100292464-A1 | OPTICAL-ISOMER SEPARATING AGENT FOR CHROMATOGRAPHY AND PROCESS FOR PRODUCING THE SAME | ORC3, OXER1, HCCS | PLA2G2A 2029/4885TP53 4325/4885TSHR 2815/4885 |
| US-20150038512-A1 | COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE | SRM, SMOX, SMS | PLA2G2A 1121/4885TP53 2932/4885TSHR 4388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.